Items Tagged ‘CML’

January 14, 2018

FDA Grants Accelerated Approval to Bosulif for Treatment of Newly-Diagnosed Chronic Myelogenous Leukemia

By

CancerConnect News: On December 19, 2017, the Food and Drug Administration granted accelerated approval to bosutinib Bosulif (bosutinib) for treatment of patients with newly-diagnosed chronic phase (CP) Philadelphia chromosome positive (Ph+) chronic myelogenous leukemia (CML). ABOUT CHRONIC MYELOGENOUS LEUKEMIA (CML) Chronic myelogenous leukemia (CML) is a rare blood cancer, which begins in the bone marrow, […]

View full entry

Tags: (Ph+), Bosulif, bosutinib, chronic myelogenous leukemia, Chronic Myeloid Leukemia, chronic phase, CML, Gleevec, Leukemia, News, Philadelphia chromosome positive


September 19, 2017

Pass it On: It’s Leukemia National Awareness Month

By

Leukemia and lymphoma are both hematologic malignancies, meaning that they involve the blood or bone marrow. The American Cancer Society (ACS) estimates that there will be 60,140 new cases of leukemia and 24,400 deaths in 2016. For lymphoma, the ACS estimates that 81,080 new cases and 21,270 deaths will occur in the United States in […]

View full entry

Tags: all, AML, CLL, CML, Leukemia, News